View in EDS PDF Full Text

Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.

Saved in:
Bibliographic Details
Title: Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.
Authors: Pérez-Díez A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Liu X; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Calderon S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Bennett A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Lisco A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Kellog A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Galindo F; Division of Clinical Research, NIAID, NIH, Bethesda, MD, United States., Memoli MJ; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Rocco JM; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Epling BP; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Laidlaw E; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Manion M; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Wortmann GW; Section of Infectious Diseases, MedStar Washington Hospital Center, Washington, DC, United States., Poon R; Division of Hospital Medicine, Georgetown University Medical Center, Washington, DC, United States., Kumar P; Division of Infectious Diseases and Tropical Medicine, Georgetown University Medical Center, Washington, DC, United States., Sereti I; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.
Source: Frontiers in immunology [Front Immunol] 2024 Apr 17; Vol. 15, pp. 1352330. Date of Electronic Publication: 2024 Apr 17 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38694513
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pérez-Díez+A%22">Pérez-Díez A</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Calderon+S%22">Calderon S</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Bennett+A%22">Bennett A</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Lisco+A%22">Lisco A</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Kellog+A%22">Kellog A</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Galindo+F%22">Galindo F</searchLink>; Division of Clinical Research, NIAID, NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Memoli+MJ%22">Memoli MJ</searchLink>; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Rocco+JM%22">Rocco JM</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Epling+BP%22">Epling BP</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Laidlaw+E%22">Laidlaw E</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Sneller+MC%22">Sneller MC</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Manion+M%22">Manion M</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Wortmann+GW%22">Wortmann GW</searchLink>; Section of Infectious Diseases, MedStar Washington Hospital Center, Washington, DC, United States.<br /><searchLink fieldCode="AU" term="%22Poon+R%22">Poon R</searchLink>; Division of Hospital Medicine, Georgetown University Medical Center, Washington, DC, United States.<br /><searchLink fieldCode="AU" term="%22Kumar+P%22">Kumar P</searchLink>; Division of Infectious Diseases and Tropical Medicine, Georgetown University Medical Center, Washington, DC, United States.<br /><searchLink fieldCode="AU" term="%22Sereti+I%22">Sereti I</searchLink>; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Apr 17; Vol. 15, pp. 1352330. <i>Date of Electronic Publication: </i>2024 Apr 17 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Intramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38694513
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1352330
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1352330
    Titles:
      – TitleFull: Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pérez-Díez A
      – PersonEntity:
          Name:
            NameFull: Liu X
      – PersonEntity:
          Name:
            NameFull: Calderon S
      – PersonEntity:
          Name:
            NameFull: Bennett A
      – PersonEntity:
          Name:
            NameFull: Lisco A
      – PersonEntity:
          Name:
            NameFull: Kellog A
      – PersonEntity:
          Name:
            NameFull: Galindo F
      – PersonEntity:
          Name:
            NameFull: Memoli MJ
      – PersonEntity:
          Name:
            NameFull: Rocco JM
      – PersonEntity:
          Name:
            NameFull: Epling BP
      – PersonEntity:
          Name:
            NameFull: Laidlaw E
      – PersonEntity:
          Name:
            NameFull: Sneller MC
      – PersonEntity:
          Name:
            NameFull: Manion M
      – PersonEntity:
          Name:
            NameFull: Wortmann GW
      – PersonEntity:
          Name:
            NameFull: Poon R
      – PersonEntity:
          Name:
            NameFull: Kumar P
      – PersonEntity:
          Name:
            NameFull: Sereti I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 04
              Text: 2024 Apr 17
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1